ASX - By Stock
|
PAA |
Re:
Top 200 PAA Shareholders as at 28 March 2024
|
|
baulko
|
55 |
14K |
1 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
55
|
14K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
baulko
|
196 |
36K |
4 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
196
|
36K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Application for quotation of securities - PAA
|
|
baulko
|
77 |
19K |
3 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
77
|
19K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAAO holders as at 29 Feb 2024
|
|
baulko
|
35 |
7.7K |
1 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
35
|
7.7K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Chart & more
|
|
baulko
|
15 |
5.0K |
6 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
15
|
5.0K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Presentation - Phase 1 Top-Line Results
|
|
baulko
|
34 |
10K |
19 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
34
|
10K
|
19
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
baulko
|
1.1K |
295K |
6 |
24/02/24 |
24/02/24 |
ASX - By Stock
|
1.1K
|
295K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
baulko
|
1.1K |
295K |
19 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
1.1K
|
295K
|
19
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
baulko
|
1.1K |
295K |
12 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
1.1K
|
295K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
baulko
|
1.1K |
295K |
14 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
1.1K
|
295K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
baulko
|
1.1K |
295K |
7 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
1.1K
|
295K
|
7
|
|
ASX - By Stock
|
FMG |
Re:
Iron ore price
|
|
baulko
|
52K |
28M |
2 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
52K
|
28M
|
2
|
|
ASX - By Stock
|
FMG |
Re:
Iron ore price
|
|
baulko
|
52K |
28M |
3 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
52K
|
28M
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Raises $3.5 Million at a Premium
|
|
baulko
|
60 |
14K |
9 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
60
|
14K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
baulko
|
87 |
18K |
12 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
87
|
18K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final MND Patient in Cohort 4 Successfully Completes Dosing
|
|
baulko
|
125 |
24K |
8 |
13/10/23 |
13/10/23 |
ASX - By Stock
|
125
|
24K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Additional Phase 1 data suggest MPL may inhibit MND
|
|
baulko
|
380 |
83K |
5 |
12/09/23 |
12/09/23 |
ASX - By Stock
|
380
|
83K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Chief Executive Officer Appointment
|
|
baulko
|
95 |
22K |
2 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
95
|
22K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Additional Phase 1 data suggest MPL may inhibit MND
|
|
baulko
|
380 |
83K |
9 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
380
|
83K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Who wants a Zoom Meeting with Management
|
|
baulko
|
28 |
4.9K |
4 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
28
|
4.9K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Epichem enters voluntary liquidation
|
|
baulko
|
218 |
50K |
7 |
21/08/23 |
21/08/23 |
ASX - By Stock
|
218
|
50K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
baulko
|
396 |
82K |
5 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
396
|
82K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
August , September , OPTOBER ,PAA
|
|
baulko
|
144 |
29K |
7 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
144
|
29K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
August , September , OPTOBER ,PAA
|
|
baulko
|
144 |
29K |
1 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
144
|
29K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
August , September , OPTOBER ,PAA
|
|
baulko
|
144 |
29K |
3 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
144
|
29K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
August , September , OPTOBER ,PAA
|
|
baulko
|
144 |
29K |
4 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
144
|
29K
|
4
|
|
ASX - By Stock
|
IBG |
Re:
Ann: Citronen Base Metals Project Update
|
|
baulko
|
51 |
22K |
1 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
51
|
22K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Trial Successfully Completes 3rd Patient Cohort
|
|
baulko
|
48 |
10K |
10 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
48
|
10K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
baulko
|
396 |
82K |
5 |
27/07/23 |
27/07/23 |
ASX - By Stock
|
396
|
82K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Motor Neurone Disease Phase 1/2 Clinical Trial Update
|
|
baulko
|
165 |
34K |
9 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
165
|
34K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Results show MPL suppresses biomarkers associated with MND
|
|
baulko
|
200 |
41K |
18 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
200
|
41K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
baulko
|
396 |
82K |
14 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
396
|
82K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Commencement of Cohort 3 in Phase 1/2 MND Trial
|
|
baulko
|
151 |
31K |
8 |
22/06/23 |
22/06/23 |
ASX - By Stock
|
151
|
31K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
baulko
|
85 |
19K |
3 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
85
|
19K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
baulko
|
85 |
19K |
4 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
85
|
19K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Motor Neurone Disease Clinical Trial Update
|
|
baulko
|
147 |
34K |
11 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
147
|
34K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Motor Neurone Disease Clinical Trial Update
|
|
baulko
|
147 |
34K |
9 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
147
|
34K
|
9
|
|
ASX - By Stock
|
SBM |
Re:
Ann: Improved Terms for Leonora from Genesis Minerals
|
|
baulko
|
7 |
3.6K |
3 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
7
|
3.6K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
MONEPANTEL - A Pan-Cancer Wonder Drug
|
|
baulko
|
84 |
21K |
12 |
08/05/23 |
08/05/23 |
ASX - By Stock
|
84
|
21K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Raises $2.5m via Placement
|
|
baulko
|
138 |
28K |
12 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
138
|
28K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
baulko
|
56 |
14K |
1 |
02/05/23 |
02/05/23 |
ASX - By Stock
|
56
|
14K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Multi Blockbuster Share??
|
|
baulko
|
73 |
17K |
9 |
18/04/23 |
18/04/23 |
ASX - By Stock
|
73
|
17K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
PAA Chart
|
|
baulko
|
282 |
73K |
4 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
282
|
73K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Stable Patient in MND trial reaches 6-months on MPL
|
|
baulko
|
70 |
16K |
12 |
29/03/23 |
29/03/23 |
ASX - By Stock
|
70
|
16K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Stable Patient in MND trial reaches 6-months on MPL
|
|
baulko
|
70 |
16K |
13 |
28/03/23 |
28/03/23 |
ASX - By Stock
|
70
|
16K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Investor Webinar Presentation
|
|
baulko
|
92 |
18K |
9 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
92
|
18K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Investor Webinar Presentation
|
|
baulko
|
92 |
18K |
8 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
92
|
18K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Canine Cancer Trial Update
|
|
baulko
|
220 |
42K |
7 |
14/03/23 |
14/03/23 |
ASX - By Stock
|
220
|
42K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Canine Cancer Trial Update
|
|
baulko
|
220 |
42K |
11 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
220
|
42K
|
11
|
|
ASX - By Stock
|
FMG |
Re:
Ann: December 2022 Quarterly Production Report
|
|
baulko
|
34 |
20K |
0 |
27/01/23 |
27/01/23 |
ASX - By Stock
|
34
|
20K
|
0
|
|